Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
Sell
-7,944
Closed -$399K 552
2018
Q2
$399K Sell
7,944
-25,220
-76% -$1.11M 0.09% 392
2018
Q1
$1.21M Sell
33,164
-7,040
-18% -$216K 0.26% 127
2017
Q4
$1.14M Sell
40,204
-55,440
-58% -$1.31M 0.22% 155
2017
Q3
$1.85M Sell
95,644
-21,201
-18% -$356K 0.27% 80
2017
Q2
$1.96M Buy
116,845
+7,777
+7% +$105K 0.23% 129
2017
Q1
$1.14M Buy
109,068
+6,530
+6% +$66.6K 0.11% 313
2016
Q4
$923K Buy
102,538
+16,530
+19% +$142K 0.08% 453
2016
Q3
$777K Buy
86,008
+59,453
+224% +$483K 0.07% 447
2016
Q2
$183K Buy
+26,555
New +$150K 0.03% 790

Other funds holding AXGN

Menta Capital's AXGN Position: Q3 2018 in Review

Menta Capital sold out of Axogen (AXGN) in Q3 2018, closing a stake of 7,944 shares — an estimated $399K sold.

Menta Capital first reported a position in AXGN in Q2 2016 and held it in 9 quarters. The position peaked at $1.96M in Q2 2017. 162 funds tracked by Wall St. Rank hold AXGN as of Q3 2018.

  • Menta Capital reported no remaining Axogen position as of Q3 2018 after selling out during the quarter.
  • Menta Capital sold 7,944 Axogen shares in Q3 2018, an estimated $399K.
  • Menta Capital first reported a position in Axogen in Q2 2016 and held it in 9 quarters.
  • Menta Capital's Axogen position peaked at $1.96M in Q2 2017.
  • 162 funds tracked by Wall St. Rank held Axogen as of Q3 2018.

Based on Menta Capital's 13F filing for Q3 2018, filed 14 Nov 2018.